13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q2 2025. See the latest, Q2 2026 →
Reported value
$580.56B
+14% on the quarter before
Positions
443
34 new · 32 sold out
Top 10
33.4%
of the value
Est. gain
+$67.44B
on stocks held all quarter
Est. return
+14.0%
on those stocks since Q1 2025
Positions as of Jun 30, 2025, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 51% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2025. Striped tiles are options.
Largest buys
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Roblox~$2.79BAdded · 0.0% → 0.6%+26,538,338 shares
- KLA~$1.92BAdded · 0.5% → 0.9%+2,146,417 shares
- Barrick Mng Corp~$1.56BNew · 0.0% → 0.3%+74,925,369 shares
- Northrop Grumman Corp~$1.56BAdded · 0.9% → 1.0%+3,113,686 shares
- Accenture Plc Ireland~$1.50BAdded · 0.4% → 0.6%+5,014,172 shares
- Salesforce~$1.29BAdded · 0.7% → 0.9%+4,740,552 shares
- T-Mobile Us Inc~$1.26BAdded · 0.4% → 0.5%+5,296,332 shares
- Amgen Inc~$1.05BAdded · 0.9% → 0.9%+3,775,911 shares
- Mondelez Intl Inc~$991.9MAdded · 0.8% → 0.8%+14,706,123 shares
- Vertex Pharmaceuticals Inc~$884.1MAdded · 0.1% → 0.2%+1,986,004 shares
Largest sells
Since Q1 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$3.44BCut · 5.4% → 7.2%−12,484,722 shares
- GE Vernova~$2.46BCut · 0.7% → 0.7%−4,641,928 shares
- Darden Restaurants Inc~$1.82BCut · 0.4% → 0.1%−8,340,376 shares
- Applied Materials~$1.68BCut · 0.4% → 0.1%−9,160,845 shares
- Abbvie Inc~$1.28BCut · 0.8% → 0.4%−6,885,308 shares
- Sap Se~$979.1MCut · 0.4% → 0.2%−3,231,330 shares
- Apple~$967.9MCut · 2.5% → 1.8%−4,718,763 shares
- Abbott Labs~$909.4MCut · 1.7% → 1.4%−6,687,339 shares
- Barrick Gold Corp~$905.1MSold out · 0.2% → 0.0%−46,556,633 shares
- Philip Morris Intl Inc~$770.8MCut · 2.9% → 2.8%−4,232,289 shares
Holdings
As of Jun 30, 2025. Changes are in shares against Mar 31, 2025, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BroadcomCOM · shares −7.6% · price +64.6% | 7.2% | $41.67B | +$16.35B | ||||||||
| MicrosoftCOM · shares +1.1% · price +32.5% | 6.8% | $39.55B | +$9.60B | ||||||||
| MetaCL A · shares −1.3% · price +28.1% | 3.1% | $18.14B | +$3.97B | ||||||||
| AlphabetCAP STK CL C · shares −0.6% · price +13.6% | 2.8% | $16.35B | +$1.95B | ||||||||
| Philip Morris Intl IncCOM · shares −4.6% · price +14.8% | 2.8% | $16.07B | +$2.07B | ||||||||
| NvidiaCOM · shares −2.3% · price +45.8% | 2.6% | $15.34B | +$4.82B | ||||||||
| AmazonCOM · shares −1.7% · price +15.3% | 2.3% | $13.45B | +$1.79B | ||||||||
| Ge AerospaceCOM NEW · shares +0.6% · price +28.6% | 2.1% | $12.25B | +$2.71B | ||||||||
| AppleCOM · shares −8.3% · price −7.6% | 1.8% | $10.74B | −$888.0M | ||||||||
| Royal Caribbean GroupCOM · shares +2.0% · price +52.4% | 1.8% | $10.22B | +$3.44B | ||||||||
| MastercardCL A · shares +0.4% · price +2.5% | 1.7% | $9.79B | +$239.4M | ||||||||
| Transdigm Group IncCOM · shares −0.4% · price +9.9% | 1.6% | $9.48B | +$856.1M | ||||||||
| Constellation Energy CorpCOM · shares −2.5% · price +60.0% | 1.6% | $9.09B | +$3.41B | ||||||||
| Abbott LabsCOM · shares −10% · price +2.5% | 1.4% | $8.18B | +$202.1M | ||||||||
| Rtx CorporationCOM · shares +2.8% · price +10.2% | 1.4% | $8.16B | +$736.8M | ||||||||
| Jpmorgan Chase & Co.COM · shares −2.2% · price +18.2% | 1.4% | $8.16B | +$1.25B | ||||||||
| Visa Inc.COM CL A · shares +0.5% · price +1.3% | 1.3% | $7.55B | +$97.8M | ||||||||
| Eli LillyCOM · shares −0.8% · price −5.6% | 1.3% | $7.34B | −$437.0M | ||||||||
| Welltower IncCOM · shares +4.9% · price +0.3% | 1.2% | $6.87B | +$21.2M | ||||||||
| Northrop Grumman CorpCOM · shares +35% · price −2.4% | 1.0% | $5.98B | −$107.5M | ||||||||
| Microstrategy IncCL A NEW · shares −0.3% · price +40.2% | 1.0% | $5.91B | +$1.70B | ||||||||
| AlphabetCAP STK CL A · shares −5.1% · price +14.0% | 1.0% | $5.86B | +$718.1M | ||||||||
| TSMCSPONSORED ADS · shares +4.8% · price +36.6% | 1.0% | $5.81B | +$1.48B | ||||||||
| Amgen IncCOM · shares +25% · price −10.4% | 0.91% | $5.28B | −$489.2M | ||||||||
| KLACOM NEW · shares +60% · price +31.8% | 0.88% | $5.12B | +$771.8M | ||||||||
| Total · 443 positions | 100% | $580.56B | +$67.44B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2025 to Q2 2025: 409 stocks held throughout, up $67.44B (+14.0%).
- Broadcom+$16.35B+65%
- Microsoft+$9.60B+32%
- Nvidia+$4.82B+46%
- Meta+$3.97B+28%
- Royal Caribbean Group+$3.44B+52%
- Amgen Inc−$489.2M−10%
- Conocophillips−$541.5M−15%
- Apple−$888.0M−8%
- Bristol-Myers Squibb Co−$972.0M−24%
- Unitedhealth Group Inc−$3.34B−40%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |